Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/164343
Title: Are macrolides as effective as fluoroquinolones in Legionella pneumonia?: YES, But...
Author: Torres Martí, Antoni
Cillóniz, Catia
Keywords: Antibiòtics
Pneumònia adquirida a la comunitat
Pneumònia
Infeccions nosocomials
Legionel·la
Antibiotics
Community-acquired pneumonia
Pneumonia
Nosocomial infections
Legionella
Issue Date: 16-Apr-2020
Publisher: Oxford University Press
Abstract: Legionella pneumonia (LP) is a well-known cause of community-acquired pneumonia (CAP) in immunocompetent patients. This intracellular pathogen is considered one of the "core microorganisms" of CAP and it is also a microorganism that can cause hospital-acquired pneumonia (HAP) either in individual cases or in the form of large-scale outbreaks. Immunosuppressed patients have a higher risk of acquiring this infection, both in the community and in the hospital, for this reason LP has to be empirically covered and intensively searched for diagnosis. Inadequate initial or delayed antibiotic treatments in LP are factors associated with a worse prognosis.
Note: Versió postprint del document publicat a: https://doi.org/10.1093/cid/ciaa442
It is part of: Clinical Infectious Diseases, 2020
URI: http://hdl.handle.net/2445/164343
Related resource: https://doi.org/10.1093/cid/ciaa442
ISSN: 1058-4838
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
701131.pdf450.96 kBAdobe PDFView/Open    Request a copy


Embargat   Document embargat fins el 31-12-2021


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.